A252 LONG-TERM OUTCOMES IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS: KINGSTON HEALTH SCIENCES CENTER LOCAL EXPERIENCE

por Greenblatt, M, Mulder, D, Flemming, J
Publicado 2023

Pro WCF: Practical Microsoft SOA Implementation

por Peiris, Chris, Bahree, A, Cicoria, S, Mulder, D, Pathak, N N
Publicado 2006

FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis

por Mulder, D J, Pacheco, I, Hurlbut, D J, Mak, N, Furuta, G T, MacLeod, R J, Justinich, C J
Publicado 2009

Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia

por den Hollander, N. C., Mulder, D. J., Graaff, R., Thorpe, S. R., Baynes, J. W., Smit, G. P. A., Smit, A. J.
Publicado 2007

The Course of Skin and Serum Biomarkers of Advanced Glycation Endproducts and Its Association with Oxidative Stress, Inflammation, Disease Severity, and Mortality during ICU Admiss...

por Meertens, John H., Nienhuis, Hans L., Lefrandt, Joop D., Schalkwijk, Casper G., Nyyssönen, Kristiina, Ligtenberg, Jack J. M., Smit, Andries J., Zijlstra, Jan G., Mulder, D. J.
Publicado 2016

(18)F-sodium fluoride positron emission tomography assessed microcalcifications in culprit and non-culprit human carotid plaques

por Hop, H., de Boer, S. A., Reijrink, M., Kamphuisen, P. W., de Borst, M. H., Pol, R. A., Zeebregts, C. J., Hillebrands, J. L., Slart, R. H. J. A., Boersma, H. H., Doorduin, J., Mulder, D. J.
Publicado 2018

[(18)F]FDG and [(18)F]NaF as PET markers of systemic atherosclerosis progression: A longitudinal descriptive imaging study in patients with type 2 diabetes mellitus

por Reijrink, M., de Boer, S. A., te Velde-Keyzer, C. A., Sluiter, J. K. E., Pol, R. A., Heerspink, H. J. L., Greuter, M. J. W., Hillebrands, J. L., Mulder, D. J., Slart, R. H. J. A.
Publicado 2021